Biology and therapeutics of cancer. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy11

Cell Line, Tumor Neoplastic Stem Cells Cell Line Tumor Cells, Cultured Breast Prostate HCT116 Cells MCF-7 Cells HT29 Cells Epithelial Cells Cells, Cultured

Organisms5

Mice, Nude Mice, SCID Mice, Inbred BALB C Mice, Inbred C57BL Mice, Transgenic

Diseases45

Neoplasms Prostatic Neoplasms Breast Neoplasms Ovarian Neoplasms Lung Neoplasms Colonic Neoplasms Stomach Neoplasms Neoplasm Metastasis Neoplasm Invasiveness Pancreatic Neoplasms Genetic Predisposition to Disease Disease Progression Uterine Cervical Neoplasms Carcinoma Carcinoma, Non-Small-Cell Lung Carcinoma, Squamous Cell Urinary Bladder Neoplasms Colorectal Neoplasms Disease Models, Animal Cell Transformation, Neoplastic Neoplasm Recurrence, Local Rectal Neoplasms Neovascularization, Pathologic Endometrial Neoplasms Esophageal Neoplasms Adenocarcinoma Head and Neck Neoplasms Liver Neoplasms Bone Neoplasms Neoplasms, Hormone-Dependent Mouth Neoplasms Neoplasms, Glandular and Epithelial Skin Neoplasms Carcinoma, Small Cell Neoplasms, Radiation-Induced Neoplasms, Second Primary Genital Neoplasms, Female Precancerous Conditions Melanoma Mammary Neoplasms, Experimental Gastrointestinal Neoplasms Brain Neoplasms Kidney Neoplasms Thyroid Neoplasms Neoplasms, Experimental

Chemicals and Drugs50

Antineoplastic Agents Cancer Vaccines Neoplasm Proteins RNA, Small Interfering RNA, Messenger Tumor Markers, Biological Receptor, erbB-2 Receptors, Estrogen Antibodies, Monoclonal MicroRNAs Tumor Suppressor Protein p53 DNA, Neoplasm Prostate-Specific Antigen Antineoplastic Agents, Phytogenic Tamoxifen Receptor, Epidermal Growth Factor Antigens, Neoplasm Fluorouracil Receptors, Progesterone Protein Kinase Inhibitors Cisplatin Antineoplastic Agents, Hormonal Paclitaxel Transcription Factors Anticarcinogenic Agents Enzyme Inhibitors Tumor Suppressor Proteins Antibodies, Monoclonal, Humanized Small Molecule Libraries DNA-Binding Proteins Drug Carriers Nuclear Proteins Proto-Oncogene Proteins Peptides Proto-Oncogene Proteins c-akt RNA, Neoplasm Proteins Antimetabolites, Antineoplastic Receptors, Androgen Deoxycytidine Taxoids Membrane Proteins Quinazolines Estrogens DNA Primers Protein-Serine-Threonine Kinases BRCA2 Protein Vascular Endothelial Growth Factor A Androgens Aptamers, Nucleotide

Analytical, Diagnostic and Therapeutic Techniques and Equipment71

Early Detection of Cancer Therapeutics Drug Delivery Systems Gene Expression Profiling Molecular Targeted Therapy Models, Biological Xenograft Model Antitumor Assays Reverse Transcriptase Polymerase Chain Reaction Prognosis Survival Analysis Clinical Trials as Topic Survival Rate Drug Design Antineoplastic Combined Chemotherapy Protocols Blotting, Western Risk Neoplasm Transplantation Retrospective Studies Disease Models, Animal Oligonucleotide Array Sequence Analysis Follow-Up Studies Neoplasm Staging Prospective Studies Registries Transplantation, Heterologous Risk Assessment Combined Modality Therapy Drug Discovery Drug Screening Assays, Antitumor Drug Evaluation, Preclinical Disease-Free Survival Sensitivity and Specificity Transfection Odds Ratio Tumor Burden Polymerase Chain Reaction Reproducibility of Results Chemotherapy, Adjuvant Immunotherapy Risk Factors Individualized Medicine Flow Cytometry Kaplan-Meier Estimate Gene Knockdown Techniques Questionnaires Multivariate Analysis Mammography SEER Program Drug Carriers Predictive Value of Tests Treatment Outcome Immunohistochemistry Tissue Array Analysis Models, Molecular Inhibitory Concentration 50 Logistic Models Radiotherapy Mammary Neoplasms, Experimental Neoplasm Grading Immunoenzyme Techniques Real-Time Polymerase Chain Reaction Confidence Intervals High-Throughput Screening Assays Drug Administration Schedule Cluster Analysis Biopsy Neoplasms, Experimental DNA Mutational Analysis Incidence Genetic Testing Diagnostic Imaging

Psychiatry and Psychology1

Phenomena and Processes54

Gene Expression Regulation, Neoplastic Mutation Drug Resistance, Neoplasm Signal Transduction Genetic Predisposition to Disease Cell Proliferation Cell Survival Risk Apoptosis RNA Interference Cell Movement DNA Methylation Dose-Response Relationship, Drug Down-Regulation Cell Division Genotype Cell Cycle Sensitivity and Specificity Phenotype Transfection Odds Ratio Gene Silencing Base Sequence Gene Expression Promoter Regions, Genetic Cell Growth Processes Up-Regulation Protein Binding Polymorphism, Genetic Genes, BRCA1 Amino Acid Sequence Phosphorylation Genes, Tumor Suppressor Genes, Neoplasm Epigenesis, Genetic Algorithms Tumor Microenvironment Inhibitory Concentration 50 Genes, p53 Cell Differentiation Transcription, Genetic Drug Synergism Germ-Line Mutation Time Factors Genetic Vectors Gene Expression Regulation Epithelial-Mesenchymal Transition Alleles Diet Postmenopause Gene Regulatory Networks Genes, BRCA2 DNA Damage Protein Structure, Tertiary

Disciplines and Occupations16

Biology Systems Biology Molecular Biology Developmental Biology Computational Biology Synthetic Biology Drug Design Pharmacology, Clinical Medical Oncology Drug Discovery Individualized Medicine Genomics Nanomedicine Proteomics Immunohistochemistry Translational Medical Research

Anthropology, Education, Sociology and Social Phenomena2

National Cancer Institute (U.S.)Quality of Life

Technology, Industry, Agriculture3

Synthetic Biology Nanoparticles Nanomedicine

Humanities2

Quality of Life History, 20th Century

Information Science9

Survival Rate Molecular Sequence Data Registries Base Sequence Questionnaires Amino Acid Sequence SEER Program Algorithms Incidence

Named Groups1

Health Care29

Pharmacy and Therapeutics Committee Survival Analysis Clinical Trials as Topic National Cancer Institute (U.S.)Survival Rate Risk Retrospective Studies Follow-Up Studies Prospective Studies Registries Risk Assessment Age Factors Disease-Free Survival Sensitivity and Specificity Odds Ratio Reproducibility of Results Risk Factors Kaplan-Meier Estimate Questionnaires Multivariate Analysis SEER Program Predictive Value of Tests Treatment Outcome American Cancer Society Logistic Models Confidence Intervals Cluster Analysis Incidence Genetic Testing

Geographicals3

United States Japan China

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Information Science Named Groups Health Care Geographicals

Biology Systems Biology Early Detection of Cancer Neoplasms Therapeutics Molecular Biology Prostatic Neoplasms Breast Neoplasms Ovarian Neoplasms Developmental Biology Lung Neoplasms Antineoplastic Agents Colonic Neoplasms Cell Line, Tumor Gene Expression Regulation, Neoplastic Stomach Neoplasms Neoplasm Metastasis Computational Biology Mice, Nude Neoplasm Invasiveness Synthetic Biology Drug Delivery Systems Pancreatic Neoplasms Pharmacy and Therapeutics Committee Gene Expression Profiling Molecular Targeted Therapy Cancer Vaccines Neoplasm Proteins Models, Biological Mutation Drug Resistance, Neoplasm Signal Transduction Xenograft Model Antitumor Assays RNA, Small Interfering Reverse Transcriptase Polymerase Chain Reaction Genetic Predisposition to Disease Disease Progression Prognosis Survival Analysis RNA, Messenger Clinical Trials as Topic Tumor Markers, Biological National Cancer Institute (U.S.)Survival Rate Uterine Cervical Neoplasms Drug Design Antineoplastic Combined Chemotherapy Protocols Carcinoma Cell Proliferation Carcinoma, Non-Small-Cell Lung Cell Survival Carcinoma, Squamous Cell Blotting, Western Pharmacology, Clinical Urinary Bladder Neoplasms Receptor, erbB-2 Colorectal Neoplasms Receptors, Estrogen Risk Neoplasm Transplantation Apoptosis RNA Interference Retrospective Studies United States Disease Models, Animal Molecular Sequence Data Oligonucleotide Array Sequence Analysis Follow-Up Studies Cell Transformation, Neoplastic Neoplastic Stem Cells Neoplasm Staging Antibodies, Monoclonal MicroRNAs Prospective Studies Registries Transplantation, Heterologous Risk Assessment Medical Oncology Combined Modality Therapy Drug Discovery Cell Movement Drug Screening Assays, Antitumor Tumor Suppressor Protein p53 Survivors Neoplasm Recurrence, Local DNA Methylation Drug Evaluation, Preclinical Age Factors Dose-Response Relationship, Drug Disease-Free Survival DNA, Neoplasm Rectal Neoplasms Down-Regulation Neovascularization, Pathologic Cell Division Genotype Cell Cycle Mice, SCID Nanoparticles Prostate-Specific Antigen

No FAQ available that match "biology and therapeutics of cancer"